HFYYX | TROZX | HFYYX / TROZX | |
Total Expense Ratio | 0.86 | 0.00 | - |
Annual Report Gross Expense Ratio | 0.86 | 0.66 | 130% |
Fund Existence | 9 years | 5 years | - |
Gain YTD | 19.544 | 21.437 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.28B | 14.8B | 15% |
Annual Yield % from dividends | 2.64 | 3.09 | 85% |
Returns for 1 year | 17.79 | 20.99 | 85% |
Returns for 3 years | 34.84 | 56.80 | 61% |
Returns for 5 years | 86.40 | 118.15 | 73% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VWYGX | 37.55 | -0.02 | -0.05% |
Voya Small Cap Growth C | |||
JNGLX | 63.56 | -0.08 | -0.13% |
Janus Henderson Global Life Sciences D | |||
RYWCX | 37.06 | -0.10 | -0.27% |
Rydex S&P SmallCap 600 Pure Growth C | |||
AIBBX | 14.19 | -0.07 | -0.49% |
Aristotle Small Cap Equity I-2 | |||
DNLDX | 58.82 | -0.30 | -0.51% |
BNY Mellon Active MidCap A |